



Cavit Sciences, Inc.: Cavit Sciences in Negotiations to Acquire Web Portal Company for Healthy Living/Wellness
PATERSON, NJ--(Marketwire - March 24, 2009) - Cavit Sciences, Inc. ("Cavit") (
After the successful launch of [ www.naturalhealthmix.com ] and our first two products, with sales starting, management has been looking for other acquisitions/mergers to complement our mission statement of offering a new and healthy way for people to live their lives.
Cavit has been actively seeking out companies that will fit with our vision. We have looked at many companies and business plans and have been in active discussions with two companies.
One is in the introduction stage at this time and one is in the final stages of negotiations to be acquired by Cavit Sciences. We feel that this company will be able to not only complement our vision but also bring sustainable and repeat revenue with the launch of its full product line.
The healthy living/wellness approach offered to people with and without insurance will mean a sustainable income for Cavit which will fit perfectly with our supplement line. The array of products and services is endless. We have seen this approach work for large companies looking to keep their employees healthy instead of fixing the health problems after the fact.
Cavit Sciences, Inc. ("Cavit") is a biotechnology company engaged in developing treatments and prevention for cancer, viral infections and related diseases along with supplements for the growing population. Additional information regarding our drug development, supplement line and Company information is available on the Company's website at: [ www.cavitsciences.com ].
Statements contained herein that are not historical fact may be forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, that are subject to a variety of risks and uncertainties. There are a number of important factors that could cause actual results to differ materially from those projected or suggested in any forward-looking statements made by Cavit. These factors include, but are not limited to: (i) the ability of Cavit to successfully raise financing, and (ii) the ability of Cavit to successfully commercialize its products in certain markets. Additional factors that would cause actual results to differ materially from those projected or suggested in any forward-looking statements are contained in Cavit's filings with the Securities and Exchange Commission, including those factors discussed under the caption "Risk Factors" for Cavit on Form 10-K filed on April 18, 2008 and its subsequently filed Forms 10-Q.